Ankur Dhingra - May 31, 2022 Form 3 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Financial Officer
Signature
/s/ Ankur Dhingra
Stock symbol
SMMT
Transactions as of
May 31, 2022
Transactions value $
$0
Form type
3
Date filed
6/2/2022, 05:38 PM
Previous filing
Mar 28, 2022
Next filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SMMT Common Stock 26.5K May 31, 2022 Direct
holding SMMT Common Stock 13.5K May 31, 2022 By Dhingra Family Revocable Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney